Keywords
References
-
1.
Papatheodoridis GV, Archimandritis AJ. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. World J Gastroenterol. 2005;11(25):3811-6. [PubMed ID: 15991274].
-
2.
Metanat M, Sharifi-Mood B, Izadi S. Prevalence of Helicobacter pylori infection in healthcare workers. Turkish J Med Sci. 2010;40(6):965-9.
-
3.
Chan FK. Non-steroidal anti-inflammatory drugs and proton-pump inhibitors vs. cyclo-oxygenase-2 selective inhibitors in reducing the risk of recurrent ulcer bleeding in patients with arthritis. Aliment Pharmacol Ther. 2005;21 Suppl 1:5-6. [PubMed ID: 15755266].
-
4.
Boltin D, Niv Y. Pharmacological and alimentary alteration of the gastric barrier. Best Pract Res Clin Gastroenterol. 2014;28(6):981-94. [PubMed ID: 25439065]. https://doi.org/10.1016/j.bpg.2014.09.001.
-
5.
Gargallo CJ, Sostres C, Lanas A. Prevention and Treatment of NSAID Gastropathy. Curr Treat Options Gastroenterol. 2014;12(4):398-413. [PubMed ID: 25209136]. https://doi.org/10.1007/s11938-014-0029-4.
-
6.
Lim YJ, Hong SJ. Helicobacter pylori infection in nonsteroidal anti-inflammatory drug users. Korean J Gastroenterol. 2014;64(2):70-5. [PubMed ID: 25168047].